We are international
Donate
TEXT SIZE   


Myeloma Minute
March 17, 2016
03.17.16
March 17, 2016
Share the Minute Facebook Tweet!
Clinical Trials
Donate to the IMF
   

 
This week's question: After relapse, I'm responding well to Rev/dex. Should I continue this treatment?


Multiple Myeloma Bone Study

New ARROW Clinical Trials: Learn How To Participate

New Selinexor STORM Clinical Trials: Learn How To Participate

New Ixazomib Clinical Trials: Learn How To Participate

Join the conversation about myeloma on the Smart Patients Message Board

Upcoming Events

March 18 - March 19, 2016
Patient & Family Seminar

Seattle, Washington

April 2, 2016
Regional Community Workshop

Denver, Colorado

April 8-9, 2016
Patient & Family Seminar

Philadelphia, Pennsylvania

April 23, 2016
Regional Community Workshop

Durham, North Carolina

 

 

 

 

 

 

 

    

x

Amidst Today's Healthcare Reality, a Shiny Vision of Medicine's Future

Famed theoretical physicist and futurist Prof. Michio Kaku portrayed a rosy healthcare future--filled with super computers and robots--at a recent talk attended by IMF Chairman Dr. Brian Durie. All well and good, Dr. Durie writes in his blog this week. But as a science-fiction fan, he was really hoping to hear an explanation of how the wormholes in the film “Interstellar” really might work. To read the blog, click HERE.

 

x

IMWG Recommendations for Diagnosis & Management of Myeloma-Related Renal Impairment


 

Recommendations developed by the International Myeloma Working Group (IMWG), the research arm of the IMF, were published online in the Journal of Clinical Oncology on March 14, 2016. The recommendations are based on data gathered through December 2015 and analyzed by Meletios A. Dimopoulos, MD, from the University of Athens in Greece, and colleagues. Patient-access is available HERE.

x

The IMF Publishes New and Updated Patient/Caregiver Materials for 2016


 

The IMF is pleased to announce the publication of several 2016 educational booklets, tips cards, and more. The updated edition of the Concise Review of the Disease and Treatment Options, an overview of myeloma, is now available. The booklets that comprise the IMF’s Understanding series have been released, and the 2016 editions include Understanding Bisphosphonate Therapy, Understanding Dexamethasone and Other Steroids, Understanding Empliciti® (elotuzumab), Understanding Freelite® and Hevylite® Tests, Understanding High-Dose Therapy with Stem Cell Rescue, Understanding Kyprolis® (carfilzomib) for injection, Understanding Treatment of Myeloma-Induced Vertebral Compression Fractures, Understanding Velcade® (bortezomib) for injection, and Understanding Your Test Results. To download these IMF publications, click HERE or request copies by calling 800-452-CURE (2873).

 

x

The IMF Presents Symposium at the Oncology Nursing Society's (ONS) 41st Annual Congress


 

On Thursday, April 28th the IMF will sponsor a symposium at the Oncology Nursing Society’s (ONS) 41st Annual Congress entitled “Updates in Multiple Myeloma: Case Studies in Collaborative Nursing and Patient Care.” Nursing professionals who attend will be eligible for 1.5 contact hours of continued nursing education. For more information or to register now, click HERE.

 x

The IMF Nurse Leadership Board Publishes "State-of-the Science" Guide to Myeloma

 

Congratulations to the IMF Nurse Leadership Board on the publication of “The Advanced Practitioner’s Guide to Multiple Myeloma,”a comprehensive supplement in the Journal of the Advanced Practitioner in Oncology (JADPRO). This collaborative work is a continuing education activity for nurse practitioners, physician assistants, clinical nurse specialists, advanced degree nurses, as well as oncology and hematology nurses, pharmacists, and physicians. The supplement provides the advanced practitioner in oncology and other oncology professionals with “the state-of-the-science information” needed to effectively manage the care of patients with multiple myeloma. To view the supplement, click HERE.

x

Register NOW for the Free "Living Well with Myeloma" Teleconference in March

 

As part of Myeloma ACTION Month, the IMF presents the “Living Well with Myeloma” teleconference series. On Thursday, March 24, 2016, at 4 PM PT / 7 PM ET, an IMF expert panel will answer your top concerns. The panelists include Drs. Brian Durie, Rafat Abonour, and S. Vincent Rajkumar. Once registered, participants will receive an email with dial-in instructions, conference ID#, and a link to slides. To register for free, click HERE.


Join Our Mailing List

 
12650 Riverside Drive, Suite 206 | North Hollywood, CA 91607-3421
IMF InfoLine: 800-452-2873 or 818-487-7455
Privacy Policy | Unsubscribe
www.myeloma.org

.

 


 related articles